MR Global(HK)Limited announced a private placement of common shares for gross proceeds of CNY 1,600 million with existing investor Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) on December 21, 2018. The transaction was approved by the board of directors of the investor at the 22nd meeting of the 6th directorate. Post the closing, the investor will maintain 100% stake in the company. The company reported total assets of CNY 3,573,476,126.34, total liabilities of CNY 2,994,651,583.17, net assets of CNY 578,824,543.17, revenue of CNY 3,347,716,930.92, and net income of CNY -143,865,708.16 for the year ended December 31, 2017.